Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Cash: 2017-2024

Historic Change in Cash for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $353.1 million.

  • Bicycle Therapeutics' Change in Cash fell 3.72% to -$73.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$242.5 million, marking a year-over-year decrease of 176.08%. This contributed to the annual value of $353.1 million for FY2024, which is 88.00% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Change in Cash stood at $353.1 million for FY2024, which was up 88.00% from $187.8 million recorded in FY2023.
  • Bicycle Therapeutics' Change in Cash's 5-year high stood at $353.1 million during FY2024, with a 5-year trough of -$99.5 million in FY2022.
  • In the last 3 years, Bicycle Therapeutics' Change in Cash had a median value of $187.8 million in 2023 and averaged $147.1 million.
  • Its Change in Cash has fluctuated over the past 5 years, first spiked by 589.92% in 2021, then crashed by 132.88% in 2022.
  • Bicycle Therapeutics' Change in Cash (Yearly) stood at $43.9 million in 2020, then surged by 589.92% to $302.7 million in 2021, then slumped by 132.88% to -$99.5 million in 2022, then skyrocketed by 288.71% to $187.8 million in 2023, then spiked by 88.00% to $353.1 million in 2024.